Tag Archive | "dealtalk"

Omega Pharma rumored to be sought after by big pharma companies

Tags: , , , , ,


Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Ingelheim GmbH are rumored to be interested in acquiring the company.  Read the full story

AstraZeneca and Pfizer in the news for another possible m&a bid

Tags: , , ,


AstraZeneca stock rose two percent to £45.67 pounds yesterday after the Swedish newspaper Dagens Industry suggested another possible Pfizer m&a  bid. AstraZeneca stocks have risen 9.5% in the last week, following a stream of good news regarding its pipeline and takeover bids by Pfizer. Read the full story

M&A rumors for buyout of Achillion Pharmaceuticals by big pharma

Tags: , , ,


UBS analyst Andrew Peters suggested that a recent takeover big in the biotech space of California-based InterMune, Inc.  by Roche was the harbinger of more M&A rumors to come. Read the full story

Roche drops business merger rumors with Chugai Pharmaceutical

Tags: , , ,


Roche had business merger rumors to buy Tokyo-based Chugai Pharmaceutical Co., Ltd. appear to be tabled for now. Sources in Roche indicated the company was focused on its $8.3 billion acquisition of California-based InterMune Inc.

Read the full story

Mylan bids on old drugs of GSK

Tags: , , , , ,


Several companies, including Mylan , have submitted a second round of bidding for a portfolio of older GlaxoSmithKline drugs.   Read the full story

Cubist Pharma, the next acquisition target for big pharmaceuticals

Tags: , ,


The timing may be right for a takeover of Cubist Pharmaceuticals. Read the full story

Roche to buy 40% stake in Chugai Pharma

Tags: ,


Roche Holding is in talks to buy the almost 40 percent of Chugai Pharmaceutical that it doesn’t already own to gain full control of its Japanese partner for oncology and arthritis drugs, according to people familiar with the matter. Read the full story

InterMune looking for oppurtunities for buyout

Tags: ,


Multiple sources are reporting that biotechnology company, InterMune, Inc. (ITMN), is officially preparing for a buyout. Read the full story

Biotech rumour mill has it that Siemens plans for a spin off

Tags: ,


Rumour mill has it that Siemens is reportedly investigating a spinout of its Siemens Healthcare division's IT unit, which could be worth more than $1 billion. Read the full story

Shire rejects AbbVie’s acquisition offer

Tags: , , , ,


Shire rejects Abbvie's $46 billion bid for acquisition. Read the full story